BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28814542)

  • 21. Advanced technologies for the molecular diagnosis of fragile X syndrome.
    Tassone F
    Expert Rev Mol Diagn; 2015; 15(11):1465-73. PubMed ID: 26489042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn screening and cascade testing for FMR1 mutations.
    Sorensen PL; Gane LW; Yarborough M; Hagerman RJ; Tassone F
    Am J Med Genet A; 2013 Jan; 161A(1):59-69. PubMed ID: 23239591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular screening for fragile X syndrome in Thailand.
    Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental and behavioral pediatricians' attitudes toward screening for fragile X.
    Acharya K; Schindler A
    Am J Intellect Dev Disabil; 2013 Jul; 118(4):284-93. PubMed ID: 23937370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and instability of fragile X alleles: implications for offering fragile X prenatal diagnosis.
    Cronister A; Teicher J; Rohlfs EM; Donnenfeld A; Hallam S
    Obstet Gynecol; 2008 Mar; 111(3):596-601. PubMed ID: 18310361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Women's attitudes toward testing for fragile X carrier status: a qualitative analysis.
    Anido A; Carlson LM; Taft L; Sherman SL
    J Genet Couns; 2005 Aug; 14(4):295-306. PubMed ID: 16047092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preimplantation genetic diagnosis for fragile X syndrome: is there increased transmission of abnormal FMR1 alleles among female heterozygotes?
    Reches A; Malcov M; Ben-Yosef D; Azem F; Amit A; Yaron Y
    Prenat Diagn; 2009 Jan; 29(1):57-61. PubMed ID: 19097038
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hair root fragile X mental retardation protein assay for the diagnosis of fragile X syndrome].
    Luo XF; Zhong JM; Zhang XZ; Zou Y; Chen Y; Wu HP; Yu XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Oct; 11(10):817-20. PubMed ID: 19849940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Public Health Literature Review of Fragile X Syndrome.
    Raspa M; Wheeler AC; Riley C
    Pediatrics; 2017 Jun; 139(Suppl 3):S153-S171. PubMed ID: 28814537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed diagnosis of fragile X syndrome--United States, 1990-1999.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Aug; 51(33):740-2. PubMed ID: 12201607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can a decision aid enable informed decisions in neonatal nursery recruitment for a fragile X newborn screening study?
    Bailey DB; Bann C; Bishop E; Guarda S; Barnum L; Roche M
    Genet Med; 2013 Apr; 15(4):299-306. PubMed ID: 23100013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Triplet expansion cytosine-guanine-guanine: Three cases of OMIM syndrome in the same family].
    González-Pérez J; Izquierdo-Álvarez S; Fuertes-Rodrigo C; Monge-Galindo L; Peña-Segura JL; López-Pisón FJ
    Med Clin (Barc); 2016 Apr; 146(7):311-5. PubMed ID: 26776484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test.
    Brown WT; Houck GE; Jeziorowska A; Levinson FN; Ding X; Dobkin C; Zhong N; Henderson J; Brooks SS; Jenkins EC
    JAMA; 1993 Oct; 270(13):1569-75. PubMed ID: 8371467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNAs and Fragile X Syndrome.
    Lin SL
    Adv Exp Med Biol; 2015; 888():107-21. PubMed ID: 26663181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fragile X syndrome.
    Saldarriaga W; Tassone F; González-Teshima LY; Forero-Forero JV; Ayala-Zapata S; Hagerman R
    Colomb Med (Cali); 2014; 45(4):190-8. PubMed ID: 25767309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fragile X mental retardation syndrome: from pathogenesis to diagnostic issues.
    Mandel JL; Biancalana V
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S158-65. PubMed ID: 15135801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-Throughput Screening Using iPSC-Derived Neuronal Progenitors to Identify Compounds Counteracting Epigenetic Gene Silencing in Fragile X Syndrome.
    Kaufmann M; Schuffenhauer A; Fruh I; Klein J; Thiemeyer A; Rigo P; Gomez-Mancilla B; Heidinger-Millot V; Bouwmeester T; Schopfer U; Mueller M; Fodor BD; Cobos-Correa A
    J Biomol Screen; 2015 Oct; 20(9):1101-11. PubMed ID: 26024946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?
    Maia N; Loureiro JR; Oliveira B; Marques I; Santos R; Jorge P; Martins S
    J Hum Genet; 2017 Feb; 62(2):269-275. PubMed ID: 27784894
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragile X analysis of 1112 prenatal samples from 1991 to 2010.
    Nolin SL; Glicksman A; Ding X; Ersalesi N; Brown WT; Sherman SL; Dobkin C
    Prenat Diagn; 2011 Oct; 31(10):925-31. PubMed ID: 21717484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.